Xingmei Liang

机构：First Affiliated Hospital Zhejiang University

发表论文 33 篇 · 总被引 260 次 · h-index 9

代表论文

• Oncolytic virus VG161 in refractory hepatocellular carcinoma (2025 · Nature · 被引 82)
• Development and evaluation of a speech-generating AAC mobile app for minimally verbal children with autism spectrum disorder in Mainland China (2017 · Molecular Autism · 被引 31)
• The Multiple Applications and Possible Mechanisms of the Hyperbaric Oxygenation Therapy (2019 · Medicinal Chemistry · 被引 30)
• Hepatoprotective effects of Yulangsan flavone against carbon tetrachloride (CCl 4 )-induced hepatic fibrosis in rats (2017 · Phytomedicine · 被引 28)
• Clinical outcomes from a phase I clinical trial of a novel oncolytic virus VG161 in patients with hepatocellular carcinoma (HCC) refractory after 2 prior lines of therapy including checkpoint inhibitors (CPI). (2024 · Journal of Clinical Oncology · 被引 10)
• Effect of Yulangsan Polysaccharide on the Reinstatement of Morphine-Induced Conditioned Place Preference in Sprague–Dawley Rats (2018 · Neurochemical Research · 被引 6)